home
developing products that
provide innovative health solutions
and address critical unmet
medical needs
BELLUS Health’s product strategy targets both pharmaceuticals and nutraceuticals. The Company’s pharmaceuticals portfolio of products includes investigational product candidates for the treatment of Amyloid A amyloidosis and Alzheimer’s disease. With respect to nutraceuticals, the Company is commercializing, through distributors, a natural health product designed to protect memory function.